Viaskin Peanut Allergy Patch Going to Clinical Trial in France
DBV Technologies announced that their Viaskin peanut allergy patch is heading to clinical trials in France.
The immunotherapy patch works by gradually exposing the patient to an allergen, teaching the body to have less of a reaction. The Viaskin patch aims to lower dangers and costs for immunotherapy treatments for the majority of those who have a peanut allergy.
New trials follow success of previous ones
The first clinical trials were held here in the U.S. with about 100 subjects. The results were deemed satisfactory and were reported to the Food and Drug Administration in late 2011.
Now, a new set of trials is set to begin in France. These trials could pave the way towards making Viaskin a marketable product.
Pending on the results of the upcoming trial, DBV is aiming to release the product to European markets in 2017 and to the U.S. in 2018.
More Articles
You already know that if you or your child has a peanut allergy you need to avoid peanut butter. Some...
There are many reasons why you may want to substitute almond flour for wheat flour in recipes. Of course, if you have a...
Are you looking for peanut-free candies as a special treat for a child with...
Do you have a child with peanut allergies and an upcoming birthday? Perhaps you'd like to bake a...
Most nut butters provide all the same benefits: an easy sandwich spread, a great dip for veggies, a fun addition to a smoothie. But not...
Top Forum Categories
Click on one of the categories below to see all topics and discussions.
| Forum Category | Number of Topics |
|---|---|
| Living With Peanut Allergy | 14, 831 |
| Manufacturers, Food: Safe and Unsafe | 6, 294 |
| Schools | 3, 547 |
| Peanut Allergy in the Media | 2, 269 |
| Welcome: Please Introduce Yourself | 1, 928 |
| Travel | 1, 429 |
| Restaurants | 1, 249 |